Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' MOREIN B' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 60 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hu, KF; Chen, M; Abusugra, I; Monaco, F; Morein, B
      Different respiratory syncytial virus and Quillaja saponin formulations induce murine peritoneal cells to express different proinflammatory cytokine profiles

      FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
    2. Hu, KF; Lovgren-Bengtsson, K; Morein, B
      Immunostimulating complexes (ISCOMs) for nasal vaccination

      ADVANCED DRUG DELIVERY REVIEWS
    3. Morein, B; Hu, KF
      Biological aspects and prospects for adjuvants and delivery systems

      NEW VACCINE TECHNOLOGIES
    4. Lovgren-Bengtsson, K; Morein, B
      The ISCOM (TM) technology

      VACCINE ADJUVANTS: PREPARATION METHODS AND RESEARCH PROTOCOLS
    5. Morein, B; Bengtsson, KL
      Immunomodulation by iscoms, immune stimulating complexes

      METHODS-A COMPANION TO METHODS IN ENZYMOLOGY
    6. Abusugra, I; Morein, B
      Iscom is an efficient mucosal delivery system for Mycoplasma mycoides subsp. mycoides (MmmSC) antigens inducing high mucosal and systemic antibody responses

      FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
    7. Behboudi, S; Morein, B; Villacres-Eriksson, MC
      Quillaja saponin formulations that stimulate proinflammatory cytokines elicit a potent acquired cell-mediated immunity

      SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    8. Hu, KF; Ekstrom, J; Merza, M; Lovgren-Bengtsson, K; Morein, B
      Induction of antibody responses in the common mucosal immune system by respiratory syncytical virus immunostimulating complexes

      MEDICAL MICROBIOLOGY AND IMMUNOLOGY
    9. Wilson, AD; Lovgren-Bengtsson, K; Villacres-Ericsson, M; Morein, B; Morgan, AJ
      The major Epstein-Barr virus (EBV) envelope glycoprotein gp340 when incorporated into Iscoms primes cytotoxic T-cell responses directed against EBV lymphoblastoid cell lines

      VACCINE
    10. Ekstrom, J; Hu, KF; Bengtsson, KL; Morein, B
      Iscom and iscom-matrix enhance by intranasal route the IgA responses to OVA and rCTB in local and remote mucosal secretions

      VACCINE
    11. Heeney, J; Akerblom, L; Barnett, S; Bogers, W; Davis, D; Fuller, D; Koopman, G; Lehner, T; Mooij, P; Morein, B; Morghen, CD; Rosenwirth, B; Verschoor, E; Wagner, R; Wolf, H
      HIV-1 vaccine-induced immune responses which correlate with protection from SHIV infection: compiled preclinical efficacy data from trials with ten different HIV-1 vaccine candidates

      IMMUNOLOGY LETTERS
    12. van Pinxteren, LAH; Bruce, MG; Campbell, I; Wood, A; Clarke, CJ; Bellman, A; Morein, B; Snodgrass, DR
      Effect of oral rotavirus/iscom vaccines on immune responses in gnotobioticlambs

      VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
    13. Verschoor, EJ; Davis, D; van Gils, M; Koopman, G; Mooij, P; Oostermeijer, H; Ten Haaft, P; Verstrepen, B; Rosenwirth, B; Morein, B; Barnett, SW; Heeney, JL
      Efforts to broaden HIV-1-specific immunity by boosting with heterologous peptides or envelope protein and the influence of prior exposure to virus

      JOURNAL OF MEDICAL PRIMATOLOGY
    14. Cooray, R; Holmberg, M; Hellstrom, A; Hardig, J; Mattsson, R; Gunnarsson, A; Borjeson, H; Lindeberg, J; Morein, B
      Screening for microorganisms associated with M74 disease syndrome in sea-run Baltic salmon (Salmo salar)

      AMBIO
    15. Verschoor, EJ; Mooij, P; Oostermeijer, H; van der Kolk, M; ten Haaft, P; Verstrepen, B; Sun, YD; Morein, B; Akerblom, L; Fuller, DH; Barnett, SW; Heeney, JL
      Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in rhesus macaques: Evidence for viral clearance

      JOURNAL OF VIROLOGY
    16. Morein, B; Villacres-Eriksson, M; Ekstrom, J; Hu, K; Behboudi, S; Lovgren-Bengtsson, K
      ISCOM: A delivery system for neonates and for mucosal administration

      ADVANCES IN VETERINARY MEDICINE, VOL 41
    17. MOREIN B; BENGTSSON KL
      FUNCTIONAL-ASPECTS OF ISCOMS

      Immunology and cell biology
    18. HANSEN DS; VILLACRESERIKSSON M; AKERBLOM L; HELLMAN U; SEGURA E; CARLOMAGNO M; MOREIN B
      AN IMMUNOAFFINITY-PURIFIED TRYPANOSOMA-CRUZI ANTIGEN SUPPRESSES CELLULAR PROLIFERATION THROUGH A TGF-BETA-MEDIATED MECHANISM

      Scandinavian journal of immunology
    19. HU KF; MOREIN B; MERZA M
      USING DISTILLED WATER FOR THE EXTRACTION OF MUCOSAL ANTIBODIES AND THE SUBSEQUENT APPLICATION IN RSV NEUTRALIZATION TEST

      Journal of immunoassay
    20. HEENEY JL; VANGILS ME; VANDERMEIDE P; MORGHEN CD; GHIONI C; GIMELLI M; RADDELLI A; DAVIS D; AKERBLOM L; MOREIN B
      THE ROLE OF TYPE-1 AND TYPE-2 T-HELPER IMMUNE-RESPONSES IN HIV-1 VACCINE PROTECTION

      Journal of medical primatology
    21. HEENEY JL; TEEUWSEN VJP; VANGILS M; BOGERS WMJM; MORGHEN CD; RADAELLI A; BARNETT S; MOREIN B; AKERBLOM L; WANG YF; LEHNER T; DAVIS D
      BETA-CHEMOKINES AND NEUTRALIZING ANTIBODY-TITERS CORRELATE WITH STERILIZING IMMUNITY GENERATED IN HIV-1 VACCINATED MACAQUES

      Proceedings of the National Academy of Sciences of the United Statesof America
    22. SAMBHARA S; WOODS S; ARPINO R; KURICHH A; TAMANE A; UNDERDOWN B; KLEIN M; BENGTSSON KL; MOREIN B; BURT D
      HETEROTYPIC PROTECTION AGAINST INFLUENZA BY IMMUNOSTIMULATING COMPLEXES IS ASSOCIATED WITH THE INDUCTION OF CROSS-REACTIVE CYTOTOXIC T-LYMPHOCYTES

      The Journal of infectious diseases
    23. HU KF; ELVANDER M; MERZA M; AKERBLOM L; BRANDENBURG A; MOREIN B
      THE IMMUNOSTIMULATING COMPLEX (ISCOM) IS AN EFFICIENT MUCOSAL DELIVERY SYSTEM FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) ENVELOPE ANTIGENS INDUCING HIGH LOCAL AND SYSTEMIC ANTIBODY-RESPONSES

      Clinical and experimental immunology
    24. VILLACRES MC; BEHBOUDI S; NIKKILA T; LOVGRENBENGTSSON K; MOREIN B
      INTERNALIZATION OF ISCOM-BORNE ANTIGENS AND PRESENTATION UNDER MHC CLASS-I OR CLASS-II RESTRICTION

      Cellular immunology
    25. BEHBOUDI S; MOREIN B; VILLACRESERIKSSON M
      IN-VIVO AND IN-VITRO INDUCTION OF IL-6 BY QUILLAJA-SAPONARIA MOLINA TRITERPENOID FORMULATIONS

      Cytokine
    26. VILLACRESERIKSSON M; BEHBOUDI S; MORGAN AJ; TRINCHIERI G; MOREIN B
      IMMUNOMODULATION BY QUILLAJA-SAPONARIA ADJUVANT FORMULATIONS - IN-VIVO STIMULATION OF INTERLEUKIN-12 AND ITS EFFECTS ON THE ANTIBODY-RESPONSE

      Cytokine
    27. PRESCOTT JF; PATTERSON MC; NICHOLSON VM; MOREIN B; YAGER JA
      ASSESSMENT OF THE IMMUNOGENIC POTENTIAL OF RHODOCOCCUS-EQUI VIRULENCE-ASSOCIATED PROTEIN (VAPA) IN MICE

      Veterinary microbiology
    28. DOTSIKA E; KARAGOUNI E; SUNDQUIST B; MOREIN B; MORGAN A; VILLACRESERIKSSON M
      INFLUENCE OF QUILLAJA-SAPONARIA TRITERPENOID CONTENT ON THE IMMUNOMODULATORY CAPACITY OF EPSTEIN-BARR-VIRUS ISCOMS

      Scandinavian journal of immunology
    29. SJOLANDER A; BENGTSSON KL; MOREIN B
      KINETICS, LOCALIZATION AND CYTOKINE PROFILE OF T-CELL RESPONSES TO IMMUNE STIMULATING COMPLEXES (ISCOMS) CONTAINING HUMAN INFLUENZA-VIRUS ENVELOPE GLYCOPROTEINS

      Vaccine
    30. RONNBERG B; FEKADU M; BEHBOUDI S; KENNE L; MOREIN B
      EFFECTS OF CARBOHYDRATE MODIFICATION OF QUILLAJA-SAPONARIA MOLINA QH-B FRACTION ON ADJUVANT ACTIVITY, CHOLESTEROL-BINDING CAPACITY AND TOXICITY

      Vaccine
    31. DAVIS D; MOREIN B; AKERBLOM L; LOVGRENBENGTSSON K; VANGILS ME; BOGERS WMJM; TEEUWSEN VJP; HEENEY JL
      A RECOMBINANT PRIME, PEPTIDE BOOST VACCINATION STRATEGY CAN FOCUS THEIMMUNE-RESPONSE ON TO MORE THAN ONE EPITOPE EVEN THOUGH THESE MAY NOTBE IMMUNODOMINANT IN THE COMPLEX IMMUNOGEN

      Vaccine
    32. ABUSUGRA I; WOLF G; BOLSKE G; THIAUCOURT F; MOREIN B
      ISCOM VACCINE AGAINST CONTAGIOUS BOVINE PLEUROPNEUMONIA (CBPP)1 - BIOCHEMICAL AND IMMUNOLOGICAL CHARACTERIZATION

      Veterinary immunology and immunopathology
    33. CAROL H; NIETO A; VILLACRESERIKSSON M; MOREIN B
      INTRANASAL IMMUNIZATION OF MICE WITH ECHINOCOCCUS-GRANULOSUS SURFACE-ANTIGENS ISCOMS EVOKES A STRONG IMMUNE-RESPONSE, BIASED TOWARDS GLUCIDIC EPITOPES

      Parasite immunology
    34. BLOMQVIST G; WESSLEN L; PAHLSON C; HJELM E; PETTERSSON B; NIKKILA T; ALLARD U; SVENSSON O; UHLEN M; MOREIN B; FRIMAN G
      PHYLOGENETIC PLACEMENT AND CHARACTERIZATION OF A NEW ALPHA-2 PROTEOBACTERIUM ISOLATED FROM A PATIENT WITH SEPSIS

      Journal of clinical microbiology
    35. SAMBHARA S; WOODS S; ARPINO R; KURICHH A; TAMANE A; BENGTSSON KL; MOREIN B; UNDERDOWN B; KLEIN M; BURT D
      INFLUENZA (H1N1)-ISCOMS ENHANCE IMMUNE-RESPONSES AND PROTECTION IN AGED MICE

      Mechanism of ageing and development
    36. BOLMSTEDT A; SJOLANDER S; HANSEN JES; AKERBLOM L; HEMMING A; HU SL; MOREIN B; OLOFSSON S
      INFLUENCE OF N-LINKED GLYCANS IN V4-V5 REGION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GLYCOPROTEIN GP160 ON INDUCTION OF A VIRUS-NEUTRALIZING HUMORAL RESPONSE

      Journal of acquired immune deficiency syndromes and human retrovirology
    37. NORDENGRAHN A; RUSVAI M; MERZA M; EKSTROM J; MOREIN B; BELAK S
      EQUINE HERPESVIRUS TYPE-2 (EHV-2) AS A PREDISPOSING FACTOR FOR RHODOCOCCUS-EQUI PNEUMONIA IN FOALS - PREVENTION OF THE BIFACTORIAL DISEASE WITH EHV-2 IMMUNOSTIMULATING COMPLEXES

      Veterinary microbiology
    38. SJOLANDER A; BENGTSSON KL; JOHANSSON M; MOREIN B
      KINETICS, LOCALIZATION AND ISOTYPE PROFILE OF ANTIBODY-RESPONSES TO IMMUNE STIMULATING COMPLEXES (ISCOMS) CONTAINING HUMAN INFLUENZA-VIRUS ENVELOPE GLYCOPROTEINS

      Scandinavian journal of immunology
    39. SJOLANDER S; HANSEN JES; LOVGRENBENGTSSON K; AKERBLOM L; MOREIN B
      INDUCTION OF HOMOLOGOUS VIRUS NEUTRALIZING ANTIBODIES IN GUINEA-PIGS IMMUNIZED WITH 2 HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GLYCOPROTEIN GP120-ISCOM PREPARATIONS - A COMPARISON WITH OTHER ADJUVANT SYSTEMS

      Vaccine
    40. TULASNE JJ; LITAMOI JK; MOREIN B; DEDIEU L; PALYA VJ; YAMI M; ABUSUGRA I; SYLLA D; BENSAID A
      CONTAGIOUS BOVINE PLEUROPNEUMONIA VACCINES - THE CURRENT SITUATION AND THE NEED FOR IMPROVEMENT

      Revue scientifique et technique - Office international des epizooties
    41. MOREIN B; VILLACRESERIKSSON M; SJOLANDER A; BENGTSSON KL
      NOVEL ADJUVANTS AND VACCINE DELIVERY SYSTEMS

      Veterinary immunology and immunopathology
    42. HANSEN DS; ALIEVI G; SEGURA EL; CARLOMAGNO M; MOREIN B; VILLACRESERIKSSON M
      THE FLAGELLAR FRACTION OF TRYPANOSOMA-CRUZI DEPLETED OF AN IMMUNOSUPPRESSIVE ANTIGEN ENHANCES PROTECTION TO INFECTION AND ELICITS SPONTANEOUS T-CELL RESPONSES

      Parasite immunology
    43. MOREIN B; BENGTSSON KL; VILLACRESERIKSSON M
      WHAT TO EXPECT OF FUTURE VACCINES

      Acta veterinaria Scandinavica
    44. SJOLANDER S; BOLMSTEDT A; AKERBLOM L; HORAL P; OLOFSSON S; MOREIN B; SJOLANDER A
      N-LINKED GLYCANS IN THE CD4-BINDING DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN GP160 ARE ESSENTIAL FOR THE IN-VIVOPRIMING OF T-CELLS RECOGNIZING AN EPITOPE LOCATED IN THEIR VICINITY

      Virology
    45. BEHBOUDI S; MOREIN B; VILLACRESERIKSSON M
      IN-VITRO ACTIVATION OF ANTIGEN-PRESENTING CELLS (APC) BY DEFINED COMPOSITION OF QUILLAJA-SAPONARIA MOLINA TRITERPENOIDS

      Clinical and experimental immunology
    46. MOREIN B; LOVGREN K; RONNBERG B; SJOLANDER A; VILLACRESERIKSSON M
      IMMUNOSTIMULATING COMPLEXES - CLINICAL POTENTIAL IN VACCINE DEVELOPMENT

      CLINICAL IMMUNOTHERAPEUTICS
    47. SNODGRASS DR; CAMPBELL I; MWENDA JM; CHEGE G; SULEMAN MA; MOREIN B; HART CA
      STIMULATION OF ROTAVIRUS IGA, IGG AND NEUTRALIZING ANTIBODIES IN BABOON MILK BY PARENTERAL VACCINATION

      Vaccine
    48. BEHBOUDI S; MOREIN B; RONNBERG B
      ISOLATION AND QUANTIFICATION OF QUILLAJA-SAPONARIA MOLINA SAPONINS AND LIPIDS IN ISCOM-MATRIX AND ISCOMS

      Vaccine
    49. FERNANDO GJP; STENZEL DJ; TINDLE RW; MERZA MS; MOREIN B; FRAZER IH
      PEPTIDE POLYMERIZATION FACILITATES INCORPORATION INTO ISCOMS AND INCREASES ANTIGEN-SPECIFIC IGG2A PRODUCTION

      Vaccine
    50. RONNBERG B; FEKADU M; MOREIN B
      ADJUVANT ACTIVITY OF NONTOXIC QUILLAJA-SAPONARIA MOLINA COMPONENTS FOR USE IN ISCOM MATRIX

      Vaccine
    51. ZUGEL U; SCHOEL B; YAMAMOTO S; HENGEL H; MOREIN B; KAUFMANN SHE
      CROSSRECOGNITION BY CD8 T-CELL RECEPTOR-ALPHA-BETA CYTOTOXIC T-LYMPHOCYTES OF PEPTIDES IN THE SELF AND THE MYCOBACTERIAL HSP60 WHICH SHARE INTERMEDIATE SEQUENCE HOMOLOGY

      European Journal of Immunology
    52. PUTKONEN P; BJORLING E; AKERBLOM L; THORSTENSSON R; LOVGREN K; BENTHIN L; CHIODI F; MOREIN B; BIBERFELD G; NORRBY E; WIGZELL H
      LONG-STANDING PROTECTION OF MACAQUES AGAINST CELL-FREE HIV-2 WITH A HIV-2 ISCOM VACCINE

      Journal of acquired immune deficiency syndromes
    53. MOREIN B; ERIKSSON MV; AKERBLOM L; RONNBERG B; LOVGREN K; SJOLANDER A
      MECHANISMS BEHIND THE IMMUNE-RESPONSE INDUCED BY IMMUNOSTIMULATING COMPLEXES

      AIDS research and human retroviruses
    54. BIBERFELD G; PUTKONEN P; THORSTENSSON R; GILLJAM G; AKERBLOM L; MOREIN B
      IMMUNIZATION OF CYNOMOLGUS MONKEYS WITH A SUBUNIT HIV-2 VACCINE

      AIDS research and human retroviruses
    55. DEVRIES P; HEENEY JL; BOES J; DINGS MEM; HULSKOTTE EGJ; DUBBES R; KOORNSTRA W; TENHAAFT P; AKERBLOM L; ERIKSSON S; MOREIN B; NORLEY S; OSTERHAUS ADME
      PROTECTION OF RHESUS MACAQUES FROM SIV INFECTION BY IMMUNIZATION WITHDIFFERENT EXPERIMENTAL SIV VACCINES

      Vaccine
    56. MERZA M; LARSSON E; STEEN M; MOREIN B
      ASSOCIATION OF A RETROVIRUS WITH A WASTING CONDITION IN THE SWEDISH MOOSE

      Virology
    57. BIBERFELD G; PUTKONEN P; THORSTENSSON R; BJORLING E; AKERBLOM L; MOREIN B; NORRBY E; WIGZELL H
      PROTECTION AGAINST HIV-2 IN VACCINATED CYNOMOLGUS MACAQUES

      AIDS research and human retroviruses
    58. FOHLMAN J; PAUKSEN K; MOREIN B; BJARE U; ILBACK NG; FRIMAN G
      HIGH-YIELD PRODUCTION OF AN INACTIVATED COXSACKIE B3 ADJUVANT VACCINEWITH PROTECTIVE EFFECT AGAINST EXPERIMENTAL MYOCARDITIS

      Scandinavian journal of infectious diseases
    59. LARSSON M; LOVGREN K; MOREIN B
      IMMUNOPOTENTIATION OF SYNTHETIC OLIGOPEPTIDES BY CHEMICAL CONJUGATIONTO ISCOMS

      Journal of immunological methods
    60. VILLACRESERIKSSON M; BERGSTROMMOLLAOGLU M; KABERG H; LOVGREN K; MOREIN B
      THE INDUCTION OF CELL-ASSOCIATED AND SECRETED IL-1 BY ISCOMS, MATRIX OR MICELLES IN MURINE SPLENIC CELLS

      Clinical and experimental immunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 12:10:07